Posts

You’ve spent the last 15 years turning your veterinary clinic into a successful operation. So, you have a full appointment calendar, loyal pet families, associate vets in place, and revenue that comfortably crosses $3M. It definitely looks like a win on paper.  But when it’s finally time to explore a sale, you expect interest, maybe…

Veterinary Practice Consolidators 2026: The Complete Directory Key takeaways The U.S. veterinary practice consolidator landscape is dominated by about ten major operators, with Mars Veterinary Health (family-owned by Mars, Incorporated, operating VCA, Banfield, and BluePearl) as the largest and the only major strategic — not PE-backed — exception. The biggest 2024-2025 structural event was the…

The veterinary roll-up race has slowed, but the chessboard it left behind is more strategic than ever. VetStrategy acquisition multiples are still the yardstick every broker cites, yet the logic behind them has shifted.   Offers that once seemed uniform now vary widely in structure, timing, and expectations. One buyer might headline an impressive multiple, another…

Buyers speak in multiples. Owners think in outcomes. Somewhere between offer and signature, the veterinary practice earn-out becomes the deal’s most misunderstood lever. It sounds like future upside, but it often means risk. Deferred payouts tied to retention, revenue, or EBITDA targets may look good on paper, yet fall short in practice. If your payout…

If you’re selling a veterinary practice to a corporation, the offer may look clean, but the trade-offs often begin where the term sheet ends. What many large clinic owners find isn’t a clear win, but a fork in the road: structure versus flexibility, familiarity versus upside, simplicity versus control. Buyers are approaching earlier and more…